Petros Pharmaceuticals annual current ratio
2020
2021
2022
2023
2024
2025
Petros Pharmaceuticals Current Ratio Growth & History (PTPI)
Petros Pharmaceuticals's current ratio was 2.25 for fiscal 2025.
View full Petros Pharmaceuticals company overviewPetros Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.25 | 1.85 | +456.61% |
| 2024 | 2024-12-31 | 0.40 | −1.49 | −78.63% |
| 2023 | 2023-12-31 | 1.89 | −0.18 | −8.78% |
| 2022 | 2022-12-31 | 2.08 | 1.09 | +110.50% |
| 2021 | 2021-12-31 | 0.99 | 0.37 | +59.44% |
| 2020 | 2020-12-31 | 0.62 | — | — |
Petros Pharmaceuticals quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.25 | −1.26 | −50.29% |
| Q1 2026 | 2026-03-31 | 1.68 | 1.14 | +214.22% |
| Q4 2025 | 2025-12-31 | 2.25 | 1.85 | +456.61% |
| Q3 2025 | 2025-09-30 | 2.22 | 1.36 | +159.80% |
| Q2 2025 | 2025-06-30 | 2.51 | 1.11 | +78.95% |
| Q1 2025 | 2025-03-31 | 0.53 | −1.06 | −66.59% |
| Q4 2024 | 2024-12-31 | 0.40 | −1.49 | −78.63% |
| Q3 2024 | 2024-09-30 | 0.85 | −2.17 | −71.76% |
| Q2 2024 | 2024-06-30 | 1.40 | −0.25 | −15.13% |
| Q1 2024 | 2024-03-31 | 1.60 | −0.42 | −20.98% |
| Q4 2023 | 2023-12-31 | 1.89 | −0.18 | −8.78% |
| Q3 2023 | 2023-09-30 | 3.02 | 0.66 | +27.95% |
| Q2 2023 | 2023-06-30 | 1.65 | −1.45 | −46.71% |
| Q1 2023 | 2023-03-31 | 2.02 | −0.59 | −22.59% |
| Q4 2022 | 2022-12-31 | 2.08 | 1.09 | +110.50% |
| Q3 2022 | 2022-09-30 | 2.36 | 1.96 | +492.74% |
| Q2 2022 | 2022-06-30 | 3.10 | 2.63 | +558.18% |
| Q1 2022 | 2022-03-31 | 2.61 | 2.01 | +337.81% |
| Q4 2021 | 2021-12-31 | 0.99 | 0.37 | +59.44% |
| Q3 2021 | 2021-09-30 | 0.40 | — | — |
| Q2 2021 | 2021-06-30 | 0.47 | — | — |
| Q1 2021 | 2021-03-31 | 0.60 | — | — |
| Q4 2020 | 2020-12-31 | 0.62 | — | — |
Petros Pharmaceuticals current ratio trends
Over the last five fiscal years, Petros Pharmaceuticals's current ratio increased from 0.62 to 2.25, a change of 1.63. The latest reported quarter, Q2 2026, shows 1.25.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Petros Pharmaceuticals source filings ↗